AbbVie
ABBV
₹15,432
Share price
2.19%
Change (1 day)
9.29%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: ₹27.299 Trillion
As of April 2025 AbbVie has a market cap of ₹27.299 Trillion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | ₹27.299 T | 1.16% |
| 2024 | ₹26.985 T | 18.48% |
| 2023 | ₹22.777 T | -3.69% |
| 2022 | ₹23.650 T | 32.74% |
| 2021 | ₹17.816 T | 28.78% |
| 2020 | ₹13.834 T | 48.16% |
| 2019 | ₹9.337 T | -2.05% |
| 2018 | ₹9.532 T | -3.3% |
| 2017 | ₹9.857 T | 42.55% |
| 2016 | ₹6.915 T | 9.11% |
| 2015 | ₹6.337 T | -3.98% |
| 2014 | ₹6.600 T | 27.44% |
| 2013 | ₹5.178 T | 75.25% |
| 2012 | ₹2.955 T |
End of Day market cap according to different sources
On Apr 23rd, 2025 the market cap of AbbVie was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | ₹11.041 T | -59.55% | 🇺🇸 USA |
 | ₹8.427 T | -69.13% | 🇺🇸 USA |
 | ₹65.503 T | 139.95% | 🇺🇸 USA |
 | ₹12.852 T | -52.92% | 🇺🇸 USA |
 | ₹11.362 T | -58.38% | 🇺🇸 USA |
 | ₹1.494 T | -94.53% | 🇺🇸 USA |
 | ₹6.455 T | -76.35% | 🇬🇧 UK |
 | ₹18.373 T | -32.69% | 🇬🇧 UK |
 | ₹883.14 B | -96.76% | 🇺🇸 USA |